Fons Guus, Hyde Simon E, Buist Marrije R, Schilthuis Marten S, Grant Peter, Burger Matthé P M, van der Velden Jacobus
Department of Gynaecologic Oncology, Academic Medical Centre, Amsterdam, the Netherlands.
Int J Gynecol Cancer. 2009 Oct;19(7):1276-80. doi: 10.1111/IGC.0b013e31819d58a1.
The aim of the current study was, first, to determine whether laterality of lymph node metastases has prognostic significance, independent of the number of lymph node metastases. Second was to determine the prognostic significance of extracapsular spread irrespective of the number of lymph node metastases.
Data on 134 patients with stage III/IVA vulva cancer from 1982 till 2004 and treated with curative intent in either the Academic Medical Centre in Amsterdam or the Mercy Hospital for Women in Melbourne were reviewed. The impact of the number of lymph node metastases, extracapsular spread, and bilateral existence of lymph node metastases on survival was determined.
The bilateral presence of lymph node metastases is not a significant predictor for survival if a correction is made for the number of lymph node metastases (hazards ratio, 1.31; 95% confidence interval, 0.68-2.51; P = 0.420). If extracapsular spread is put into the model as well, this is the only parameter of prognostic significance in multivariate analysis (hazards ratio, 5.27; 95% confidence interval, 2.60-10.67; P < 0.001). The five-year survival of patients with extracapsular spread is only 31%, which is considerably lower than the 80% survival of patients with only intracapsular metastases.
In conclusion, there is growing evidence that bilateral existence of lymph node metastases is not a sufficient variable to qualify stage. Extracapsular spread, however, seems to be the most valuable lymph node-associated prognostic factor for survival.
本研究的目的,其一,确定淋巴结转移的侧别是否具有预后意义,独立于淋巴结转移的数量。其二,确定无论淋巴结转移数量多少,包膜外扩散的预后意义。
回顾了1982年至2004年在阿姆斯特丹学术医疗中心或墨尔本仁慈妇女医院接受根治性治疗的134例III/IVA期外阴癌患者的数据。确定了淋巴结转移数量、包膜外扩散以及淋巴结转移的双侧性对生存的影响。
如果对淋巴结转移数量进行校正,淋巴结转移的双侧性不是生存的显著预测因素(风险比,1.31;95%置信区间,0.68 - 2.51;P = 0.420)。如果将包膜外扩散也纳入模型,这是多变量分析中唯一具有预后意义的参数(风险比,5.27;95%置信区间,2.60 - 10.67;P < 0.001)。有包膜外扩散的患者的五年生存率仅为31%,这显著低于仅有无包膜内转移患者的80%生存率。
总之,越来越多的证据表明,淋巴结转移的双侧性不是分期的充分变量。然而,包膜外扩散似乎是与生存相关的最有价值的淋巴结预后因素。